GlassScriptPhysician profile
Debra L Shemesh
NPI 1528063989
$3,130.98
in general payments reported to CMS, 2019-2025
26 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $601 · 2022: $775 · 2023: $651 · 2024: $811 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,755.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $858.46 | 2021-2025 | |
| Pfizer INC. | $248.23 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $237.38 | 2022-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $166.11 | 2023-2025 | Onpattro |
| Cvrx, INC. | $157.53 | 2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $143.47 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $140.91 | 2021-2024 | Camzyos |
| Atricure, INC. | $134.82 | 2023-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Amgen INC. | $133.05 | 2021-2024 | Repatha |
| Abbott Laboratories | $117.99 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Janssen Pharmaceuticals, INC | $115.81 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.80 | 2021-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $97.57 | 2022-2024 | Uptravi, Opsumit |
| Esperion Therapeutics, INC. | $68.90 | 2021-2024 | Nexletol |
| Medtronic, INC. | $60.24 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.56 | 2021-2024 | Jardiance |
| Irhythm Technologies, INC. | $55.07 | 2022-2023 | Zio Xt Patch |
| Kowa Pharmaceuticals America, INC. | $41.64 | 2021-2023 | Livalo |
| Boston Scientific Corporation | $37.79 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $33.74 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $28.44 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $23.95 | 2021 | |
| Astellas Pharma US INC | $22.51 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.19 | 2022 | |
| Amarin Pharma, INC. | $15.94 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $15.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Shemesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.